The effects of estrogen deficiency and bisphosphonate treatment on tissue mineralisation and stiffness in an ovine model of osteoporosis

Journal of Biomechanics

Volumn 44, Issue 3, 2011, Pages 386-390

  Brennan, O ^a,b   Kennedy, O D ^a,b   Lee, T C ^a,b   Rackard, S M ^c   O'Brien, F J ^a,b   McNamara, L M ^d  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c UNIVERSITY COLLEGE DUBLIN   (Ireland)

^d NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Bisphosphonate; Bone; Estrogen; Mineralisation; Ovariectomy; Stiffness

Indexed keywords

BACKSCATTER ELECTRON IMAGING; BISPHOSPHONATES; BONE TISSUE; CONTROL GROUPS; DISEASED BONE; ESTROGEN; MINERAL CONTENT; MINERAL DISTRIBUTION; MINERALISATION; OVARIECTOMY; OVINE MODEL; PROXIMAL FEMUR; SPATIAL DISTRIBUTION; SPECIFIC LOCATION; TISSUE MODULUS; ZOLEDRONIC ACID;

ANIMALS; BONE; GYNECOLOGY; MECHANICAL PROPERTIES; MINERALOGY; MINERALS; NANOINDENTATION; SILICATE MINERALS; STIFFNESS;

BIOMECHANICS;

ESTROGEN; ZOLEDRONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MINERAL; BONE MINERALIZATION; BONE STRUCTURE; BONE TURNOVER; CONTROLLED STUDY; DRUG EFFECT; ESTROGEN DEFICIENCY; FEMALE; MUSCULOSKELETAL STIFFNESS; NANOANALYSIS; NONHUMAN; OSTEOPOROSIS; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SHEEP; TISSUE CHARACTERIZATION; TISSUE DISTRIBUTION; TRABECULAR BONE;

ANIMALS; BIOMECHANICS; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; BONE RESORPTION; DIPHOSPHONATES; ESTROGENS; FEMALE; IMIDAZOLES; MODELS, ANIMAL; OSTEOPOROSIS; OVARIECTOMY; SHEEP;

EID: 78651466765     PISSN: 00219290     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbiomech.2010.10.023     Document Type: Article

References (42)

1. Amin D., Cornell S.A., Gustafson S.K., Needle S.J., Ullrich J.W., Bilder G.E., Perrone M.H. Bisphosphonates used for the treatment of bone disorders inhibit squalene synthase and cholesterol biosynthesis. Journal of Lipid Research 1992, 33(11):1657-1663.
2. Anumula S., Wehrli S.L., Magland J., Wright A.C., Wehrli F.W. Ultra-short echo-time MRI detects changes in bone mineralization and water content in OVX rat bone in response to alendronate treatment. Bone 2010, 46(5):1391-1399.
3. Bitto A., Burnett B.P., Polito F., Marini H., Levy R.M., Armbruster M.A., Minutoli L., Di Stefano V., Irrera N., Antoci S., Granese R., Squadrito F., Altavilla D. Effects of genistein aglycone in osteoporotic, ovariectomized rats: a comparison with alendronate, raloxifene and oestradiol. British Journal of Pharmacology 2008, 155(6):896-905.
4. Boivin G., Meunier P.J. Changes in bone remodeling rate influence the degree of mineralization of bone. Connective Tissue Research 2002, 43(2-3):535-537.
5. Borah B., Ritman E.L., Dufresne T.E., Jorgensen S.M., Liu S., Sacha J., Phipps R.J., Turner R.T. The effect of risedronate on bone mineralization as measured by micro-computed tomography with synchrotron radiation: correlation to histomorphometric indices of turnover. Bone 2005, 37(1):1-9.
6. Boyde A., Compston J.E., Reeve J., Bell K.L., Noble B.S., Jones S.J., Loveridge N. Effect of estrogen suppression on the mineralization density of iliac crest biopsies in young women as assessed by backscattered electron imaging. Bone 1998, 22(3):241-250.
7. Brennan O., Kennedy O.D., Lee T.C., Rackard S.M., O'Brien F.J. Biomechanical properties across trabeculae from the proximal femur of normal and ovariectomised sheep. Journal of Biomechanics 2009, 42(4):498-503.
8. Burr D.B., Miller L., Grynpas M., Li J., Boyde A., Mashiba T., Hirano T., Johnston C.C. Tissue mineralization is increased following 1-year treatment with high doses of bisphosphonates in dogs. Bone 2003, 33(6):960-969.
9. Cheng Z., Yao W., Zimmermann E.A., Busse C., Ritchie R.O., Lane N.E. Prolonged treatments with antiresorptive agents and PTH have different effects on bone strength and the degree of mineralization in old estrogen-deficient osteoporotic rats. Journal of Bone and Mineral Research 2009, 24(2):209-220.
10. Choi K., Kuhn J.L., Ciarelli M.J., Goldstein S.A. The elastic moduli of human subchondral, trabecular, and cortical bone tissue and the size-dependency of cortical bone modulus. Journal of Biomechanics 1990, 23(11):1103-1113.
11. Ciarelli T.E., Fyhrie D.P., Parfitt A.M. Effects of vertebral bone fragility and bone formation rate on the mineralization levels of cancellous bone from white females. Bone 2003, 32(3):311-315.
12. Crick D.C., Andres D.A., Waechter C.J. Novel salvage pathway utilizing farnesol and geranylgeraniol for protein isoprenylation. Biochemical and Biophysical Research Communications 1997, 237(3):483-487.
13. Day J.S., Ding M., Bednarz P., van der Linden J.C., Mashiba T., Hirano T., Johnston C.C., Burr D.B., Hvid I., Sumner D.R., Weinans H. Bisphosphonate treatment affects trabecular bone apparent modulus through micro-architecture rather than matrix properties. Journal of Orthopaedic Research 2004, 22(3):465-471.
14. Dickenson R.P., Hutton W.C., Stott J.R. The mechanical properties of bone in osteoporosis. Journal of Bone and Joint Surgery British Volume 1981, 63-B(2):233-238.
15. Eriksen E.F., Axelrod D.W., Melsen F. Bone Histomorphometry 1994, Raven Press, New York.
16. Fisher J.E., Rodan G.A., Reszka A.A. In vivo effects of bisphosphonates on the osteoclast mevalonate pathway. Endocrinology 2000, 141(12):4793-4796.
17. Follet H., Boivin G., Rumelhart C., Meunier P.J. The degree of mineralization is a determinant of bone strength: a study on human calcanei. Bone 2004, 34(5):783-789.
18. Gadeleta S.J., Boskey A.L., Paschalis E., Carlson C., Menschik F., Baldini T., Peterson M., Rimnac C.M. A physical, chemical, and mechanical study of lumbar vertebrae from normal, ovariectomized, and nandrolone decanoate-treated cynomolgus monkeys (Macaca fascicularis). Bone 2000, 27(4):541-550.
19. Gourion-Arsiquaud S., Allen M.R., Burr D.B., Vashishth D., Tang S.Y., Boskey A.L. Bisphosphonate treatment modifies canine bone mineral and matrix properties and their heterogeneity. Bone 2010, 46(3):666-672.
20. Grynpas M. Age and disease-related changes in the mineral of bone. Calcified Tissue International 1993, 53(Suppl 1):S57-S64.
21. Grynpas M.D., Acito A., Dimitriu M., Mertz B.P., Very J.M. Changes in bone mineralization, architecture and mechanical properties due to long-term (1 year) administration of pamidronate (APD) to adult dogs. Osteoporosis International 1992, 2(2):74-81.
22. Healy C., Kennedy O.D., Brennan O., Rackard S.M., O'Brien F.J., Lee T.C. Structural adaptation and intracortical bone turnover in an ovine model of osteoporosis. Journal of Orthopaedic Research 2010, 28(2):248-251.
23. Hornby S.B., Evans G.P., Hornby S.L., Pataki A., Glatt M., Green J.R. Long-term zoledronic acid treatment increases bone structure and mechanical strength of long bones of ovariectomized adult rats. Calcified Tissue International 2003, 72(4):519-527.
24. Kennedy O.D., Brennan O., Rackard S.M., Staines A., O'Brien F.J., Taylor D., Lee T.C. Effects of ovariectomy on bone turnover, porosity, and biomechanical properties in ovine compact bone 12 months postsurgery. Journal of Orthopaedic Research 2009, 27(3):303-309.
25. Krassas G.E., Papadopoulou P. Oestrogen action on bone cells. Journal of Musculoskeletal and Neuronal Interactions 2001, 2(2):143-151.
26. Li B., Aspden R.M. Material properties of bone from the femoral neck and calcar femorale of patients with osteoporosis or osteoarthritis. Osteoporos Int 1997, 7(5):450-456.
27. McNamara L.M. Perspective on post-menopausal osteoporosis: establishing an interdisciplinary understanding of the sequence of events from the molecular level to whole bone fractures. Journal of the Royal Society Interface 2010, 7(44):353-372.
28. McNamara L.M., Ederveen A.G., Lyons C.G., Price C., Schaffler M.B., Weinans H., Prendergast P.J. Strength of cancellous bone trabecular tissue from normal, ovariectomized and drug-treated rats over the course of ageing. Bone 2006, 39(2):392-400.
29. Mulder L., Koolstra J.H., den Toonder J.M., van Eijden T.M. Intratrabecular distribution of tissue stiffness and mineralization in developing trabecular bone. Bone 2007, 41(2):256-265.
30. Mulder L., Koolstra J.H., den Toonder J.M., van Eijden T.M. Relationship between tissue stiffness and degree of mineralization of developing trabecular bone. Journal of Biomedical and Materials Research Part A 2007, 84(2):508-515.
31. Ott S.M. Theoretical and methodological approach. Principles of Bone Biology 1996, Academic Press, San Diego, CA, pp. 231-241. J.P. Bilezikian, L.G. Raisz, G.R. Rodan (Eds.).
32. Pan B., To L.B., Farrugia A.N., Findlay D.M., Green J., Gronthos S., Evdokiou A., Lynch K., Atkins G.J., Zannettino A.C. The nitrogen-containing bisphosphonate, zoledronic acid, increases mineralisation of human bone-derived cells in vitro. Bone 2004, 34(1):112-123.
33. Reid I.R., Brown J.P., Burckhardt P., Horowitz Z., Richardson P., Trechsel U., Widmer A., Devogelaer J.P., Kaufman J.M., Jaeger P., Body J.J., Brandi M.L., Broell J., Di Micco R., Genazzani A.R., Felsenberg D., Happ J., Hooper M.J., Ittner J., Leb G., Mallmin H., Murray T., Ortolani S., Rubinacci A., Saaf M., Samsioe G., Verbruggen L., Meunier P.J. Intravenous zoledronic acid in postmenopausal women with low bone mineral density. New England Journal of Medicine 2002, 346(9):653-661.
34. Reinholz G.G., Getz B., Pederson L., Sanders E.S., Subramaniam M., Ingle J.N., Spelsberg T.C. Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts. Cancer Research 2000, 60(21):6001-6007.
35. Reinholz G.G., Getz B., Sanders E.S., Karpeisky M.Y., Padyukova N., Mikhailov S.N., Ingle J.N., Spelsberg T.C. Distinct mechanisms of bisphosphonate action between osteoblasts and breast cancer cells: identity of a potent new bisphosphonate analogue. Breast Cancer Research and Treatment 2002, 71(3):257-268.
36. Renders G.A., Mulder L., van Ruijven L.J., van Eijden T.M. Degree and distribution of mineralization in the human mandibular condyle. Calcified Tissue International 2006, 79(3):190-196.
37. Roschger P., Fratzl P., Eschberger J., Klaushofer K. Validation of quantitative backscattered electron imaging for the measurement of mineral density distribution in human bone biopsies. Bone 1998, 23(4):319-326.
38. Ruffoni D., Fratzl P., Roschger P., Phipps R., Klaushofer K., Weinkamer R. Effect of temporal changes in bone turnover on the bone mineralization density distribution: a computer simulation study. Journal of Bone and Mineral Research 2008, 23(12):1905-1914.
39. Shahnazari M., Yao W., Dai W., Wang B., Ionova-Martin S.S., Ritchie R.O., Heeren D., Burghardt A.J., Nicolella D.P., Kimiecik M.G., Lane N.E. Higher doses of bisphosphonates further improve bone mass, architecture, and strength but not the tissue material properties in aged rats. Bone 2010, 46(5):1267-1274.
40. Silva M.J., Brodt M.D., Fan Z., Rho J.Y. Nanoindentation and whole-bone bending estimates of material properties in bones from the senescence accelerated mouse SAMP6. Journal of Biomechanics 2004, 37(11):1639-1646.
41. Spadaro J.A., Damron T.A., Horton J.A., Margulies B.S., Murray G.M., Clemente D.A., Strauss J.A. Density and structural changes in the bone of growing rats after weekly alendronate administration with and without a methotrexate challenge. Journal of Orthopaedic Research 2006, 24(5):936-944.
42. Yao W., Balooch G., Balooch M., Jiang Y., Nalla R.K., Kinney J., Wronski T.J., Lane N.E. Sequential treatment of ovariectomized mice with bFGF and risedronate restored trabecular bone microarchitecture and mineralization. Bone 2006, 39(3):460-469.